Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Brazilian Thalassemia Association protocol for iron chelation therapy in patients under regular transfusion.

Veríssimo MP, Loggetto SR, Fabron Junior A, Baldanzi GR, Hamerschlak N, Fernandes JL, Araujo Ada S, Lobo CL, Fertrin KY, Berdoukas VA, Galanello R.

Rev Bras Hematol Hemoter. 2013;35(6):428-34. doi: 10.5581/1516-8484.20130106.

2.

Ferritin trends do not predict changes in total body iron in patients with transfusional iron overload.

Puliyel M, Sposto R, Berdoukas VA, Hofstra TC, Nord A, Carson S, Wood J, Coates TD.

Am J Hematol. 2014 Apr;89(4):391-4. doi: 10.1002/ajh.23650. Epub 2014 Feb 28.

3.

X-linked lymphoproliferative disease: prenatal detection of an unaffected histocompatible male.

Mulley JC, Turner AM, Gedeon AK, Berdoukas VA, Huang TH, Ledbetter DH, Grierson H, Purtilo DT.

Clin Genet. 1992 Aug;42(2):76-9.

PMID:
1358486
4.

Report on the X-linked lymphoproliferative disease in an Australian family.

Turner AM, Berdoukas VA, Tobias VH, Ziegler JB, Toogood IR, Mulley JC, Skare J, Purtilo DT.

J Paediatr Child Health. 1992 Apr;28(2):184-9.

PMID:
1562373
5.

Plasmapheresis in children with Guillain-Barré syndrome.

Lamont PJ, Johnston HM, Berdoukas VA.

Neurology. 1991 Dec;41(12):1928-31.

PMID:
1745351
6.

Sustained normalization of cardiac function by chelation therapy in thalassaemia major.

Freeman AP, Giles RW, Berdoukas VA, Talley PA, Murray IP.

Clin Lab Haematol. 1989;11(4):299-307.

PMID:
2605872
7.

A study on the value of red cell exchange transfusion in transfusion dependent anaemias.

Berdoukas VA, Kwan YL, Sansotta ML.

Clin Lab Haematol. 1986;8(3):209-20.

PMID:
3093137
8.

A new application of plasma exchange in insulin dependent diabetes mellitus.

Charlton B, Cooper SG, Brown AS, Berdoukas VA, Gurtunca N, Rudkowski R, Antony G.

Biomed Pharmacother. 1985;39(1):19-22.

PMID:
3896334
9.

Plasmapheresis in intractable insulin-resistant diabetes.

Antony G, Berdoukas VA, Charlton B, Cooper SG, Gurtünca N, Kelly WH.

Lancet. 1983 Nov 12;2(8359):1148-9. No abstract available.

PMID:
6138681
10.

Early left ventricular dysfunction and chelation therapy in thalassemia major.

Freeman AP, Giles RW, Berdoukas VA, Walsh WF, Choy D, Murray PC.

Ann Intern Med. 1983 Oct;99(4):450-4.

PMID:
6625375
11.

Homozygous beta-thalassaemia in a part-Aboriginal Australian.

Vowels MR, Grunseit F, Webster BH, Berdoukas VA.

Med J Aust. 1983 Aug 6;2(3):139-41.

PMID:
6877146
12.

Community-initiated screening programme for beta-thalassaemia trait.

Berdoukas VA, Webster BH, Raddatz B.

Med J Aust. 1983 Aug 6;2(3):129-31.

PMID:
6877143
13.

Haemoglobinopathies: a review. Part 1.

Holcombe YM, Berdoukas VA.

Med J Aust. 1981 Feb 7;1(3):115-6, 135. No abstract available.

PMID:
7219281
14.

Haematological aspects of antenatal diagnosis for thalassaemia in Britain.

Matsakis M, Berdoukas VA, Angastiniotis M, Mouzouras M, Ioannou P, Ferrari M, Modell B, Fairweather DV, Ward RH, Loukopoulos D, Sakarellou N.

Br J Haematol. 1980 Oct;46(2):185-97.

PMID:
7426453
15.

Rhodotorulic acid--investigation of its potential as an iron-chelating drug.

Grady RW, Peterson CM, Jones RL, Graziano JH, Bhargava KK, Berdoukas VA, Kokkini G, Loukopoulos D, Cerami A.

J Pharmacol Exp Ther. 1979 Jun;209(3):342-8.

PMID:
108388

Supplemental Content

Loading ...
Support Center